UIC
SBRA icon

Uniplan Investment Counsel’s Sabra Healthcare REIT SBRA Stock Holding History

Uniplan Investment Counsel’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.77M Sell
248,230
-17,094
-6% -$337K 0.49% 56
2025
Q4 		$5.03M Sell
265,324
-5,945
-2% -$110K 0.5% 57
2025
Q3 		$5.06M Buy
271,269
+86,792
+47% +$1.62M 0.5% 57
2025
Q2 		$3.4M Sell
184,477
-4,056
-2% -$72K 0.34% 73
2025
Q1 		$3.29M Buy
+188,533
New +$3.18M 0.32% 84

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Uniplan Investment Counsel's SBRA Position: Q1 2026 in Review

Uniplan Investment Counsel reduced its Sabra Healthcare REIT (SBRA) stake by 6.4% in Q1 2026, selling an estimated $337K and leaving 248,230 shares worth $4.77M. The position accounts for 0.49% of the portfolio, ranked #56.

Uniplan Investment Counsel first reported a position in SBRA in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.06M in Q3 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Uniplan Investment Counsel held 248,230 shares of Sabra Healthcare REIT worth $4.77M as of Q1 2026.
  • Uniplan Investment Counsel sold 17,094 Sabra Healthcare REIT shares in Q1 2026, an estimated $337K.
  • Sabra Healthcare REIT made up 0.49% of Uniplan Investment Counsel's portfolio in Q1 2026, its #56 holding.
  • Uniplan Investment Counsel first reported a position in Sabra Healthcare REIT in Q1 2025 and has held it in 5 quarters since.
  • Uniplan Investment Counsel's Sabra Healthcare REIT position peaked at $5.06M in Q3 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.